Neha Krishnamohan - 07 Jun 2021 Form 3 Insider Report for Kinnate Biopharma Inc.

Signature
/s/ Mark A. Meltz, attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
3
Filing time
08 Jun 2021, 20:30:19 UTC
Next filing
15 Feb 2022

No securities are beneficially owned.